13
MCTD Rheumatoid Arthritis Sjögren's
Against
long-term GCs
¶
Against
long-term GCs
¶
Against
long-term GCs
¶
Conditional recommendation against
Conditional recommendation
Strong recommendation against
People with progression
of ILD on first ILD therapy*
Add or Switch Therapy
†
Referral for lung-transplant evaluation at
appropriate time for progressive disease
Mycophenolate
Rituximab
Nintedanib
‡
Tocilizumab
Cyclophosphamide
IVIG
Mycophenolate
Rituximab
Nintedanib
‡
Tocilizumab
Cyclophosphamide
Pirfenidone
Mycophenolate
Rituximab
Nintedanib
‡
Cyclophosphamide
